[GESIDA survey on antiretroviral treatment in 1998. Working Group for the Study of AIDS (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)].
Miró
J M
JM
Hospital Clínic Universitari, Barcelona. miro@medicina.ub.es
Arrizabalaga
J
J
Gatell
J M
JM
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D006306:Health Surveys; D006761:Hospitals / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D010820:Physicians / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013030:Spain
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors
Encuesta GESIDA sobre el tratamiento antirretroviral en 1998. Grupo de Estudio de SIDA (GESIDA) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).